Official: Merck to help produce rival J&J's COVID-19 vaccine

This September 2020, file photo provided by Johnson & Johnson shows a pharmacist preparing to give an experimental COVID-19 vaccine. The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday, Feb. 27, 2021 cleared a Johnson & Johnson shot that works with just one dose instead of two. (Johnson & Johnson via AP, File)

This September 2020, file photo provided by Johnson & Johnson shows a pharmacist preparing to give an experimental COVID-19 vaccine. The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday, Feb. 27, 2021 cleared a Johnson & Johnson shot that works with just one dose instead of two. (Johnson & Johnson via AP, File)

To view this content you must be logged in as a subscriber.
Already have a digital account? Log in here
4 WEEKS
$12.50

UNLIMITED

DIGITAL ACCESS

4 WEEKS

52 WEEKS
$135

UNLIMITED

DIGITAL ACCESS

FOR 52 WEEKS

DAY PASS
$2.00

UNLIMITED

DIGITAL ACCESS

FOR 24 HOURS

Plans include full website access, e-Edition and exclusive online extras.
Print and Digital combo plans also available.
ALREADY A PRINT SUBSCRIBER?
dcourier subscribe logo

Donate Report a Typo Contact
Most Read